H. Lundbeck A/S (HLBBF)
OTCMKTS
· Delayed Price · Currency is USD
5.74
+0.12 (2.04%)
At close: May 22, 2025
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $5.61 billion as of June 6, 2025. Its market cap has increased by 5.92% in one year.
Market Cap
5.61B
Enterprise Value
7.52B
Revenue
3.33B
Ranking
n/a
PE Ratio
11.78
Stock Price
$5.74
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 5.61B, an increase of 23.67%. That is a compound annual growth rate of 7.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 5.61B | 2.30% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.66B |
| Veradigm | 747.25M |
| Nika Pharmaceuticals | 666.65M |
| Tian'an Technology Group | 637.25M |
| Elite Pharmaceuticals | 619.60M |
| Glass House Brands | 443.99M |
| CytoDyn | 437.04M |
| Northwest Biotherapeutics | 391.68M |